Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Carbapenem derivado")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 2067

  • Page / 83
Export

Selection :

  • and

Novel carbapenem-hydrolyzing oxacillinase OXA-62 from Pandoraea pnomenusaSCHNEIDER, Ines; QUEENAN, Anne Marie; BAUERNFEIND, Adolf et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 4, pp 1330-1335, issn 0066-4804, 6 p.Article

Carbapenems: Past, Present, and FuturePAPP-WALLACE, Krisztina M; ENDIMIANI, Andrea; TARACILA, Magdalena A et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 11, pp 4943-4960, issn 0066-4804, 18 p.Article

Appropriate use of the carbapenemsBRINK, A. J; FELDMAN, C; GROLMAN, D. C et al.SAMJ. South African medical journal. 2004, Vol 94, Num 10, pp 857-861, issn 0256-9574, 5 p., 2Article

Activities of doripenem (S-4661) against drug-resistant clinical pathogensJONES, Ronald N; HUYNH, Holly K; BIEDENBACH, Douglas J et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 8, pp 3136-3140, issn 0066-4804, 5 p.Article

Carbapenem antibiotics for serious infectionsHAWKEY, Peter M; LIVERMORE, David M.BMJ (Overseas and retired doctors ed.). 2012, Vol 344, Num 7863, pp 43-47, issn 1759-2151, 5 p.Article

Comparative Antipneumococcal Activities of Sulopenem and Other DrugsKOSOWSKA-SHICK, Klaudia; EDNIE, Lois M; MCGHEE, Pamela et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 6, pp 2239-2247, issn 0066-4804, 9 p.Article

Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter spHOSSAIN, Ashfaque; FERRARO, M. J; PINO, R. M et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 11, pp 4438-4440, issn 0066-4804, 3 p.Article

An Ongoing National Intervention to Contain the Spread of Carbapenem-Resistant EnterobacteriaceaeSCHWABER, Mitchell J; CARMELI, Yehuda.Clinical infectious diseases. 2014, Vol 58, Num 5, pp 697-703, issn 1058-4838, 7 p.Article

DoripenemPATERSON, David L; DEPESTEL, Daryl D.Clinical infectious diseases. 2009, Vol 49, Num 2, pp 291-298, issn 1058-4838, 8 p.Article

Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenemBHAVNANI, Sujata M; HAMMEL, Jeffrey P; CIRINCIONE, Brenda B et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 9, pp 3944-3947, issn 0066-4804, 4 p.Article

Ertapenem: a Group 1 carbapenem with distinct antibacterial and pharmacological propertiesHAMMOND, Milton L.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, pp ii7-ii9, issn 0305-7453, SUP2Article

Managing Transmission of Carbapenem-Resistant Enterobacteriaceae in Healthcare Settings: A View From the TrenchesPALMORE, Tara N; HENDERSON, David K.Clinical infectious diseases. 2013, Vol 57, Num 11, pp 1593-1599, issn 1058-4838, 7 p.Article

Juvenile toxicity study of faropenem medoxomil in beagle puppiesFAQI, Ali S; LANPHEAR, Chery; GILL, Stan et al.Reproductive toxicology (Elmsford, NY). 2010, Vol 30, Num 4, pp 619-624, issn 0890-6238, 6 p.Article

Safety of Intravenous Infusion of DoripenemREDMAN, Rebecca; FILE, Thomas M.Clinical infectious diseases. 2009, Vol 49, issn 1058-4838, S28-S35, SUP1Article

Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing β-lactamaseALBA, Jimena; ISHII, Yoshikazu; THOMSON, Kenneth et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 11, pp 4760-4762, issn 0066-4804, 3 p.Article

Carbapenem Resistance in Elizabethkingia meningoseptica Is Mediated by Metallo-β-Lactamase BlaBGONZALEZ, Lisandro J; VILA, Alejandro J.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 4, pp 1686-1692, issn 0066-4804, 7 p.Article

The new treatment paradigm and the role of carbapenemsMASTERTON, Robert G.International journal of antimicrobial agents (Print). 2009, Vol 33, Num 2, pp 105-110, issn 0924-8579, 6 p.Article

Efficacy of Intravenous Infusion of DoripenemRESTREPO, Marcos I.Clinical infectious diseases. 2009, Vol 49, issn 1058-4838, S17-S27, SUP1Article

Pharmacokinetics and disposition of CS-023 (RO4908463), a novel parenteral carbapenem, in animalsSHIBAYAMA, Takahiro; MATSUSHITA, Yoko; KAWAI, Kenji et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 1, pp 257-263, issn 0066-4804, 7 p.Article

Safety and tolerability of ertapenemTEPPLER, Hedy; GESSER, Richard M; FRIEDLAND, Ian R et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, pp ii75-ii81, issn 0305-7453, SUP2Article

Carbapenem De-escalation Therapy in a Resource-Limited SettingAPISARNTHANARAK, Anucha; BHOOANUSAS, Nuntanij; YAPRASERT, Apiwat et al.Infection control and hospital epidemiology. 2013, Vol 34, Num 12, pp 1310-1313, issn 0899-823X, 4 p.Article

Mise au point sur le doripénème = Focus on doripenemRéanimation (Paris. 2001). 2009, Vol 18, issn 1624-0693, 22 p., SUP2Serial Issue

In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenemKOGA, Tetsufumi; ABE, Tomomi; SHIBAYAMA, Takahiro et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 8, pp 3239-3250, issn 0066-4804, 12 p.Article

In vitro antimicrobial activity of doripenem, a new carbapenemYIGONG GE; WIKLER, Matthew A; SAHM, Daniel F et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 4, pp 1384-1396, issn 0066-4804, 13 p.Article

Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluationsJONES, Ronald N; HUYNH, Holly K; BIEDENBACH, Douglas J et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 54, Num 1, pp 144-154, issn 0305-7453, 11 p.Article

  • Page / 83